hero section gradient
9 handpicked stocks

Big Tech

Join the tech revolution with stocks from innovation leaders like Apple, Amazon, and Tesla. These carefully selected companies are reshaping our world through AI, cloud computing, and digital transformation.

Author avatar

Han Tan | Market Analyst

Published on May 19

Your Basket's Financial Footprint

Summary and investor takeaways for the 'Big Tech' basket based on provided market capitalisation breakdown.

Key Takeaways for Investors:
  • Large-cap dominance tends to mean lower volatility and more stable returns, typically tracking broad market movements.
  • Use as a core, long-term holding for diversification rather than a speculative, high-growth allocation.
  • Expect steady long-term appreciation; short-term explosive gains are less likely given the large-cap concentration.
Total Market Cap
  • AAPL: $3.90T

  • MSFT: $3.85T

  • AMZN: $2.37T

  • Other
≈

About This Group of Stocks

1

Our Expert Thinking

These tech giants aren't just industry leaders - they're architects of our future. From AI and cloud computing to electric vehicles and social connectivity, these companies are driving unprecedented innovation across multiple sectors with strong growth potential.

2

What You Need to Know

Big Tech stocks typically outperform the market over time and represent significant portions of major indices. While they can experience volatility, their market dominance, vast resources, and continuous innovation make them core holdings for many investors.

3

Why These Stocks

We've selected the most influential tech companies that are reshaping our digital landscape. Each has demonstrated market leadership, innovation capabilities, and the financial strength to invest in emerging technologies that will define our future.

Why You'll Want to Watch These Stocks

🚀

Industry Dominance

These tech giants control massive market share in their respective industries, from cloud computing to digital advertising and streaming, positioning them to capitalize on growing digital trends.

💡

Innovation Leaders

Big Tech companies invest billions in R&D, pioneering breakthroughs in AI, autonomous vehicles, and virtual reality that could create entirely new revenue streams and market opportunities.

🌐

Global Growth Potential

With established presence in developed markets and expanding reach in emerging economies, these tech leaders are tapping into billions of new users worldwide.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

🚀

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Global Infrastructure Partners: UAE Exposure Risks

Global Infrastructure Partners: UAE Exposure Risks

The UAE's strategic push for economic diversification and smart city development is creating significant demand for advanced construction and infrastructure solutions. This basket provides exposure to a selection of US and EU-listed companies that supply essential materials, technology, and engineering services to the region's projects.

UAE Infrastructure Global Suppliers Breakdown

UAE Infrastructure Global Suppliers Breakdown

As the UAE continues its ambitious economic diversification, demand for world-class infrastructure creates opportunities for the companies that build it. This basket offers exposure to US and EU-listed industrial, materials, and technology firms that are integral to developing these large-scale projects.

Antiviral M&A Wave: Biotech Opportunities in 2025

Antiviral M&A Wave: Biotech Opportunities in 2025

Merck's $9.2 billion acquisition of Cidara Therapeutics strengthens its antiviral pipeline as a key patent nears expiry. This major deal signals a growing trend of pharmaceutical giants buying smaller biotechs, creating potential opportunities among companies with promising infectious disease therapies.

Frequently Asked Questions